Skip to main content
. 2022 Mar 23;8(1):29–35. doi: 10.5114/ceh.2022.114169

Table 3.

Validity (AUC, sensitivity, specificity) for NLR, PLR, ALBI, CTP, MELD-Na, and ABR to discriminate the 3 groups

DLC patients (n = 97) vs. compensated cirrhosis patients (n = 20)
AUC p 95% CI Cut-off Sensitivity Specificity PPV NPV
NLR 0.698 0.005* 0.559-0.836 > 1.942# 82.47 60.0 90.9 41.4
PLR 0.535 0.625 0.408-0.662
ALBI 0.828 < 0.001* 0.726-0.931 > –0.85 76.29 85.0 96.1 42.5
ABR 0.798 < 0.001* 0.695-0.901 ≤ 2.667 78.35 75.0 93.2 34.9
CTP score 0.982 < 0.001* 0.963-1.000 > 7# 95.88 90.0 97.9 81.8
MELD-Na 0.745 0.001* 0.616-0.874 > 10.9# 93.81 55.0 91.0 64.7
ALF patients (n = 32) vs. compensated cirrhosis patients (n = 20)
NLR 0.856 < 0.001* 0.748-0.964 > 3.3947# 87.50 75.0 84.8 78.9
PLR 0.681 0.029* 0.528-0.834 > 100.575 71.87 65.0 76.7 59.1
ALBI 0.859 < 0.001* 0.750-0.968 > –0.85 81.25 85.0 89.7 73.9
ABR 0.912 < 0.001* 0.825-0.999 ≤ 1.846# 90.62 85.0 90.6 85.0
CTP score 0.946 < 0.001* 0.892-1.000 > 7 84.37 90.0 93.1 78.3
MELD-Na 0.969 < 0.001* 0.930-1.000 > 22 87.50 95.0 96.6 82.6
ALF patients (n = 32) vs. DLD patients (n = 97)
NLR 0.734 < 0.001* 0.635-0.832 > 5.26# 75.0 64.95 41.4 88.7
PLR 0.619 0.044* 0.513-0.725 > 100.19 71.87 50.52 32.4 84.5
ALBI 0.517 0.775 0.403-0.631 > –0.309 50.0 57.73 28.1 77.8
ABR 0.680 0.002* 0.575-0.786 ≤ 0.9048 53.13 72.16 38.6 82.4
CTP score 0.637 0.020* 0.515-0.760 ≤ 9# 59.38 70.10 39.6 84.0
MELD-Na 0.888 < 0.001* 0.828-0.949 > 21.9 90.62 68.04 48.3 95.7

AUC – area under curve, p value – probability value, CI – confidence interval, NPV – negative predictive value, PPV – positive predictive value, DLC – decompensated liver cirrhosis

*Statistically significant at p ≤ 0.05

#Cut-off was chosen according to Youden index